NDC 69729-615-01 - PENIMIXCINA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69729-615
- Requested NDC
- 69729-615-01
- Package NDCs from labels
- 69729-615-01, 69729-615-05
- Manufacturer
- OPMX LLC
- Effective date
- 2024-05-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PENIMIXCINA - OPMX LLC | OPMX LLC | 2024-05-17 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-05-19 | Penimixcina - First Aid Ointment |
| 2024-01-30 | Penimixcina - First Aid Ointment |
| 2022-10-19 | Penimixcina - First Aid Ointment |
| 2020-01-31 | Penimixcina - First Aid Ointment |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69729-615-01 | PENIMIXCINA | 14 g in 1 TUBE | OINTMENT | 14 | 5 | |
| 69729-615-05 | PENIMIXCINA | 1 in 1 BOX | OINTMENT | 1 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Bryant Ranch Prepack | 3c5e1833-9908-4e4f-bdf2-7a28c14a585c | 2023-07-18 | Adverse reactions | 88AYB867L5 |
| MAXITROL | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Novartis Pharmaceuticals Corporation | 22c6d2db-85af-4a3b-a014-80d901a86717 | 2023-06-27 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Bactine Max Antibiotic and Lidocaine Max Pain Relief | LIDOCAINE | WellSpring Pharmaceutical Corporation | 71300df9-6113-4f25-93ca-28ad7e7f79de | 2023-06-08 | Warnings | 89Y4M234ES 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | Bausch & Lomb Incorporated | 4456d10b-9995-4430-b692-a8859ea36deb | 2023-06-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | Proficient Rx LP | 21c9b34c-af88-4c9e-9b6c-32d78d34ba7e | 2023-05-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC | A-S Medication Solutions | c895676f-446a-4a93-a3d2-addcce96b108 | 2023-01-23 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Polymyxin B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 72dd6de6-31d6-4a8f-881b-91af91ed9314 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Neomycin Sulfate | NEOMYCIN SULFATE | Teva Pharmaceuticals USA, Inc. | 777dbfab-f83e-4738-ae1e-78619a9f82a7 | 2022-10-12 | Boxed warning, Warnings, Adverse reactions | 057Y626693 |
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Proficient Rx LP | 548089f3-29d8-4ba8-af21-9e04356ac29c | 2022-10-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | f5ef71ae-fca9-4a57-ae88-f2b2d195a179 | 2022-08-01 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| BHI Skin | BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR | MediNatura Inc | 70ab2931-bd2d-43de-bb36-d019f78e3d73 | 2022-07-07 | Warnings | 4T6H12BN9U |
| REFRESH P.M. | MINERAL OIL, PETROLATUM | Allergan, Inc. | 24365d64-cd94-41cc-a7e1-033102d98114 | 2022-06-30 | Warnings | 4T6H12BN9U |
| hydrocortisone acetate pramoxine HCl | HYDROCORTISONE ACETATE, PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 982f0862-2be8-4a65-8b61-8f3a95ab5951 | 2022-05-31 | Adverse reactions | 88AYB867L5 |
| Hydrocortisone Acetate Pramoxine Hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 87a4c494-56f9-48f6-8592-d610c507a4fc | 2022-05-31 | Adverse reactions | 88AYB867L5 |
| hydrocortisone acetate pramoxine hcl | HYDROCORTISONE ACETATE PRAMOXINE HCL | Padagis Israel Pharmaceuticals Ltd | 9eea5875-d153-4bba-aee2-b1d1cd8b5e57 | 2022-05-31 | Adverse reactions | 88AYB867L5 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 98042cef-2839-49d6-a7bd-a1d29c74430b | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 601cab21-c211-4c34-be7b-f4fdd97a921a | 2022-05-02 | Warnings, Adverse reactions | 057Y626693 19371312D4 |
| Polymyxin B | POLYMYXIN B SULFATE | Hikma Pharmaceuticals USA Inc. | 18daf0d1-b6f5-46f4-ab2f-01a594f3959c | 2022-04-28 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM | Proficient Rx LP | 1252b997-3a81-4f3c-90e4-92f29ba15713 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B Sulfate and Trimethoprim | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | Proficient Rx LP | d1f55327-156f-44cd-b0fc-b1a938e8aa73 | 2022-04-01 | Warnings, Adverse reactions | 19371312D4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.